Tissue engineering of retina through high resolution 3-dimensional inkjet bioprinting.
Animals
Bioprinting
/ instrumentation
Cell Proliferation
Humans
Photoreceptor Cells
/ cytology
Printing, Three-Dimensional
/ instrumentation
Retina
/ cytology
Retinal Pigment Epithelium
/ cytology
Rhodopsin
/ metabolism
Swine
Tissue Engineering
/ instrumentation
Tissue Scaffolds
/ chemistry
Vascular Endothelial Growth Factor A
/ metabolism
Journal
Biofabrication
ISSN: 1758-5090
Titre abrégé: Biofabrication
Pays: England
ID NLM: 101521964
Informations de publication
Date de publication:
31 01 2020
31 01 2020
Historique:
pubmed:
3
10
2019
medline:
15
12
2020
entrez:
3
10
2019
Statut:
epublish
Résumé
The mammalian retina contains multiple cellular layers, each carrying out a specific task. Such a controlled organization should be considered as a crucial factor for designing retinal therapies. The maintenance of retinal layered complexity through the use of scaffold-free techniques has recently emerged as a promising approach for clinical ocular tissue engineering. In an attempt to fabricate such layered retinal model, we are proposing herein a unique inkjet bioprinting system applied to the deposition of a photoreceptor cells (PRs) layer on top of a bioprinted retinal pigment epithelium (RPE), in a precise arrangement and without any carrier material. The results showed that, after bioprinting, both RPE and PRs were well positioned in a layered structure and expressed their structural markers, which was further demonstrated by ZO1, MITF, rhodopsin, opsin B, opsin R/G and PNA immunostaining, three days after bioprinting. We also showed that considerable amounts of human vascular endothelial growth factors (hVEGF) were released from the RPE printed layer, which confirmed the formation of a functional RPE monolayer after bioprinting. Microstructures of bioprinted cells as well as phagocytosis of photoreceptor outer segments by apical RPE microvilli were finally established through transmission electron microscopy (TEM) imaging. In summary, using this carrier-free bioprinting method, it was possible to develop a reasonable in vitro retina model for studying some sight-threatening diseases, such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP).
Identifiants
pubmed: 31578006
doi: 10.1088/1758-5090/ab4a20
doi:
Substances chimiques
Vascular Endothelial Growth Factor A
0
Rhodopsin
9009-81-8
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM